Drugs & cosmetics act 1940


Published on

Published in: Health & Medicine, Business
No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • F exp
  • Drugs & cosmetics act 1940

    1. 1. Prepared by : Rakshit V. Thumar M.Pharm Q.A. SEM-II Guided by: Ms. Urvisha V. Bangoriya Assistant professorQuality Assurance Department S. J. Takkar Pharmacy college Rajkot SJTPC 1
    2. 2. Contents History and Objectives Definitions Administration of the act and rules Provisions related to Import Provisions related to Manufacture Provisions related to Sale Labeling and Packaging Schedules to the act and rules Recent amendment act, 2008 List of forms SJTPC 2
    3. 3. History British misrule-Providing poor healthcare system to Indian citizens Observations made by-Drugs Enquiry Committee, Indian Medical Association Reports in- Indian Medical Gazette during 1920-30 1940 – Drugs and Cosmetics Act 1945 – Rules under the ActExtended to whole of India…… SJTPC 3
    4. 4. LIST OF AMENDING ACTS AND ADAPTATION ORDERS1. The Drugs (Amendment) Act, 19552. The Drugs (Amendment) Act, 19603. The Drugs (Amendment) Act, 19624. The Drugs and Cosmetics (Amendment) Act, 19645. The Drugs and Cosmetics (Amendment) Act, 19726. The Drugs and Cosmetics (Amendment) Act, 19827. The Drugs and Cosmetics (Amendment) Act, 19958. The Drugs and cosmetics (Amendment) Act, 2008 SJTPC 4
    5. 5. Objectives To regulate the import, manufacture, distribution and sale of drugs & cosmetics through licensing. Manufacture, distribution and sale of drugs and cosmetics by qualified persons only. To prevent substandard in drugs. To regulate the manufacture and sale of Ayurvedic, Siddha and Unani drugs. To establish Drugs Technical Advisory Board(DTAB) and Drugs Consultative Committees(DCC) for Allopathic and allied drugs and cosmetics. SJTPC 5
    6. 6. DefinitionsDrugs : All medicines for internal or external use of human beings or animals and all substances intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder in human beings or animals, including preparations applied on human body for the purpose of repelling insects like mosquitoes. SJTPC 6
    7. 7. Cosmetic : Any article intended to be rubbed, poured, sprinkled or sprayed on, or introduced into, or otherwise applied to, the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, and includes any article intended for use as a component of cosmetic. SJTPC 7
    8. 8.  Misbranded drugs : (a) if it is so coloured, coated, powdered or polished that damage is concealed or if it is made to appear of better or greater therapeutic value than it really is; or (b) if it is not labelled in the prescribed manner. SJTPC 8
    9. 9.  Adulterated drug : (a) if it consists, in whole or in part, of any filthy, putrid or decomposed substance; or (b) if it has been prepared, packed or stored under insanitary conditions whereby it may have been contaminated with filth or whereby it may have been rendered injurious to health; or (c) if its container is composed in whole or in part, of any poisonous or deleterious substance which may render the contents injurious to health. SJTPC 9
    10. 10.  Spurious drugs : (a) if it is imported under a name which belongs to another drug; or (b) if it is an imitation of, or a substitute for, another drug or resembles another drug in a manner likely to deceive or bears upon it or upon its label or container the name of another drug SJTPC 10
    11. 11.  Manufacture : In relation to any drug or cosmetic, it includes any process or part of a process for making, altering, ornamenting, finishing, pac king, labelling, breaking up or otherwise treating or adopting any drug or cosmetic with a view to its sale or distribution but does not include the compounding or dispensing of any drug, or the packing of any drug or cosmetic, in the ordinary course of retail business. SJTPC 11
    12. 12.  Patent or Proprietary medicine : A drug which is a remedy or prescription presented in a form ready for internal or external administration of human beings or animals and which is not included in the edition of the Indian Pharmacopoeia for the time being or any other Pharmacopoeia authorized in this behalf by the Central Government. SJTPC 12
    13. 13. Administration of the act and rulesA) Advisory : 1)Drugs Technical Advisory Board-DTAB 2)Drugs Consultative Committee-D.C.C.B) Analytical : 1)Central Drugs Laboratory - CDL 2)Drug Control Laboratory in states 3)Government AnalystsC) Executives : 1)Licensing authorities 2)Controlling authorities 3)Drug Inspectors SJTPC 13
    14. 14. Drugs Technical Advisory Board(DTAB) Ex-Officio:(i) Director General of Health Services (Chairman)(ii) Drugs Controller, India(iii)Director of the Central Drugs Laboratory, Calcutta(iv) Director of the Central Research Institute, Kasauli(v)Director of Indian Veterinary Research Institute, Izatnagar(vi) President of Medical Council of India(vii) President of the Pharmacy Council of India(viii)Director of Central Drug Research Institute, Lucknow SJTPC 14
    15. 15.  Nominated:1) Two persons by the Central Government.2) One person by the Central Government from the pharmaceutical industry3) Two persons holding the appointment of Government Analyst under this Act, SJTPC 15
    16. 16.  Elected:1)one person, to be elected by the Executive Committee of the Pharmacy Council of India,2)one person, to be elected by the Executive Committee of the Medical Council of India,3)one pharmacologist to be elected by the Governing Body of the Indian Council of Medical Research;4)one person to be elected by the Central Council of the Indian Medical Association;5)one person to be elected by the Council of the Indian Pharmaceutical Association; SJTPC 16
    17. 17.  Functions: To advise the Central Government and the State Governments on technical matters. To carry out the other functions assigned to it by this Act. SJTPC 17
    18. 18. Drugs Consultative Committee(DCC) It is also an advisory body constituted by central government. Constitution: Tworepresentatives of the Central Government One representative of each State Government SJTPC 18
    19. 19.  Functions: To advise the Central Government, the State Governments and the Drugs Technical Advisory Board on any other matter tending to secure uniformity throughout India in the administration of this Act. The Drugs Consultative Committee shall meet when required Has power to regulate its own procedure. SJTPC 19
    20. 20. Central Drug Laboratory(CDL) Established in Calcutta, under the control of a director appointed by the Central Government.Functions: Analysis or test of samples of drugs/cosmetics sent by the custom collectors or courts. Analytical Q.C. of the imported samples. Collection, storage and distribution of internal standards. Preparation of reference standards and their maintenance. Maintenance of microbial cultures. Any other duties entrusted by Central Government. Acting as an appellate authority in matter of disputes. SJTPC 20
    21. 21. Drug control laboratories in stateIn gujarat three laboratories established which collect, analysed and report the various sample of the drugs and food.1) Baroda: Established in 1959.2) Bhuj: Established in 1979.3) Rajkot: Established in 1983The laboratory has the following devision:- Pharmaceutical Chemistry Division Immunology Division Pharmacology Division Pharmacognocy Division Food Division Ayurvedic Division SJTPC 21
    22. 22. Function: Testing of drug sample Analysis of food sample Analysis of exicse sample SJTPC 22
    23. 23. Government analyst These officers are appointed by the central or state government and perform the duties.Qualification of government analysist1 Persons having qualification for appointment as government as govermental Analysis for allopathic drugs ;2 having a degree in medicine, ayurved, sidha or unani system and not less than three year post graduate experience in the analysis of drugs in a laboratory under control of a government analyst. SJTPC 23
    24. 24. Duties: 1) The Government Analyst shall cause to be analysed or tested such samples or drugs and cosmetics as may be sent to him by Inspectors. 2)A Government Analyst shall from time to time forward reports to the Government giving the result of analytical work and research with a view to their publication. SJTPC 24
    25. 25. Licencing authorityQualification:(i) Graduate in Pharmacy on Pharmaceutical Chemistry or in Medicine with specialization in clinical pharmacology or microbiology from a University established in India by law; and(ii)Experience in the manufacture or testing of drugs a minimum period of five years, Provided that the requirements as to the academic qualification shall not apply to those inspectors . SJTPC 25
    26. 26. Duties:(1) to inspect all establishments licensed for the sale of drugs within the area assigned to him;(2) to satisfy himself that the conditions of the licences are being observed;(3) to procure and send for test or analysis, if necessary, imported packages.(4) to investigate any complaint. SJTPC 26
    27. 27. (5) to maintain a record of all inspections made and action taken by him in the performance of his duties,(6) to make such enquiries and inspections as may be necessary to detect the sale of drugs in contravention to the Act; SJTPC 27
    28. 28. Controlling authorityQualification: graduate in Pharmacy or Pharmaceutical Chemistry or in Medicine with specialization in clinical Pharmacology or microbiology from a University established in India by law and experience in the manufacture or testing of drugs or enforcement of the provisions of the Act for a minimum period of five years: SJTPC 28
    29. 29. Drug InspectorQualification1 Persons having qualification for appointment as government as govermental Analysis for allopathic drugs ; or2 having a degree in ayurved, sidha or unani system and not less than three year post graduate experience in the analysis of drugs in a laboratory under control of (a) a government analyst, or (b) a chemical examinar, or (c) head of an institution specially approved for this purpose. SJTPC 29
    30. 30. Power:a) Inspect, --(i) any premises where in any drug or cosmetic is being manufactured.(ii) any premises where in any drug or cosmetic is being sold, or stocked or exhibited or offered for sale, or distributed ;(b) Take samples of any drug or cosmetic,--(i) which is being manufactured or being sold or is stocked or exhibited or offered for sale, or is being distributed;(ii) from any person who is in the course of conveying, delivering or preparing to deliver such drug or cosmetic to a purchaser or a consignee. SJTPC 30
    31. 31. Provision of Act Manufacturi LabelingImport Sales ng & Packaging SJTPC 31
    32. 32. IMPORTSJTPC 32
    33. 33. IMPORT of drugs Classes of drugs prohibited to import Import of drug under license 1)Specified in Schedule-C/C1 2)Specified in Schedule-X 3)Imported for Test/Analysis 4)Imported for personal use 5)Any new drugs Drugs exempted from provisions of import Offences and Penalties SJTPC 33
    34. 34. Classes of drugs prohibited to import Misbranded drugs Drugs of substandard quality Drugs claiming to cure diseases specified in Sch-J Adulterated drugs Spurious drugs Drugs whose manufacture, sale/distribution are prohibited in original country, except for the purpose of test, examination and analysis. Patent/Proprietary medicines whose true formula is not disclosed. SJTPC 34
    35. 35. Import of the biological drugs(C/C1)Conditions to be fulfillled: Licensee must have adequate facility for the storage. Licensee must maintain a record of the sale. Licensee must allow an inspector to inspect premises and to check the records. Licensee must furnish the sample to the authority. Licensee must not sell drugs from which sample is withdrawn and he is advised not to sale, and recall the batch from the market. SJTPC 35
    36. 36. Import of the Schedule-X drugs(Narcotic & Psychotropic drugs)Conditions to be fulfilled: Licensee must have adequate storage facility. Applicant must be reputable in the occupation, trade or business. The license granted even before should not be suspended or cancelled. The licensee has not been convicted any offence under the Drugs and Cosmetics Act or Narcotic and Psychotropic Substances Act. SJTPC 36
    37. 37. Drugs Imported for examination, test or analysis Conditions to be fulfilled: License is necessary under form-11 Must use imported drugs only for said purpose and at the place specified in the license. Must keep the record with respect to quantities, name of the manufacturer and date of import. Must allow an inspector to inspect the premises and check the records. SJTPC 37
    38. 38. Drugs imported for personal useConditions to be fulfilled: Up to 100 average doses may be imported without any permit, provided it is part of passenger’s luggage. More than 100 doses imported with license. Apply on form no.-12-A,12-B Drugs must be bonafide personal use. Drugs must be declared to the custom collectors if so directed. SJTPC 38
    39. 39. Import of drugs without license Substances not used for medicinal pupose Drugs in Sch-C1 required for manufacturing and not for medicinal use. Substances which are both drugs and foods such as: Condensed/Powdered Milk Malt Lactose Farex/Cereal Oats Predigested foods Ginger, Pepper, Cumin, Cinnamon SJTPC 39
    40. 40. Penalties related to Import OFFENCES PENALTIESImport of spurious OR a) 3 years imprisonment andadulterated drug OR drug which 5000 Rs. fine on firstinvolves risk to human beings or convictionanimals OR drug not having b) 5 years imprisonment ORtherapeutic values 1000 Rs. fine OR both for subsequent convictionContravention of the provision a) 6 months imprisonment OR 500 Rs. fine OR both for first conviction b) 1 year imprisonment OR 1000 Rs. fine for subsequent offence SJTPC 40
    41. 41. Cosmetics prohibited to import Misbranded cosmetics Spurious cosmetics Cosmetic containing harmful ingredients Cosmetics not of standard quality which contains more than-2 ppm Arsenic, 20 ppm lead, 100 ppm heavy metals SJTPC 41
    43. 43. Manufacture Prohibition of manufacture Manufacture of other than in Sch-C/C1 Manufacture of those in Sch-C/C1 Manufacture of Sch-X drugs Loan license Repackaging license Offences & Penalties SJTPC 43
    44. 44. Prohibition of manufacture Drug not of standard quality or misbranded, adulterated or spurious. Patent or Proprietary medicine Drugs in Sch-J Risky to human beings or animals Drugs without therapeutic value Preparation containing cyclamates SJTPC 44
    45. 45. Manuf. of drugs other than in Sch-C/C1 Conditions:  Premises should comply with schedule ‘M’  Adequate facility for testing, separate from manufacturing  Adequate storage facility  Records maintained for at least 2 years from date of Exp.  Should provide sample to authority  Furnish data of stability  Maintain the inspection book  Maintain reference samples from each batch SJTPC 45
    46. 46. Manuf. of drugs those in Schedule-C/C1(Biological)Conditions: Drugs must be issued in previously sterilized sealed glass or suitable container Containers should comply with Sch-F Some classes tested for aerobic & anaerobic micro- organism.eg. Sera ,Insulin, Pituitary hormones. Serum tested for abnormal toxicity Parentral in doses of 10 ml or more should be tested for freedom from Pyrogens Separate lab. for culture & manipulation of spore bearing Pathogens Test for sterility should be carried out. SJTPC 46
    47. 47. Manufacture Of Sch-X drugsConditions: Accounts of all transactions regarding manuf. should be maintained in serially.(Preserved for 5 years) Have to sent invoice of sale to licensing authority every 3 months Store drugs in direct custody of responsible person. Preparation must be labeled with XRx Marketed in packings not exceeding  100 unit dose –Tablets/Capsules  300 ml- Oral liquid  5 ml - Injection SJTPC 47
    48. 48. Loan License Definition: A person(applicant) who does not have his own arrangements(factory) for manufacture but who wish to manufacturing facilities owned by another licensee. Such licenses are called Loan licenses.Loan licenses are issued for: 1) Drugs other than specified in C/C1 & X. 2) Drugs specified in Schedule-C/C1 SJTPC 48
    49. 49. Repackaging license Definition: Process of breaking up any drug from a bulk container into small packages and labeling with a view to their sale and distribution. Repackaging of drugs is granted of drugs other than Schdule-C/C1 and X. SJTPC 49
    50. 50. Penalties related to Manufacture OFFENCES PENALTIESManufacture of any spurious drugs a) 1-3 years imprisonment and Rs.5000 fine b) 2-6 years imprisonment & Rs.10000 fine on subsequent convictionManufacture of adulterated drugs a) 1 year imprisonment & Rs.2000 fine b) 2 years imprisonment & Rs.2000 fine for subsequent convictionManuf. of drugs in contravention of a) Imprisonment up to 3 months &the provisions Rs.500 fine b) Imprisonment up to 6 months & Rs.1000 fine on subsequent conviction SJTPC 50
    51. 51. Manufacture of cosmeticsProhibited for the following classes of drug: Misbranded or spurious cosmetics and of substandard quality Cosmetics containing hexachlorophene or mercury compounds Cosmetics containing color which contain more than- - 2 ppm of arsenic - 20 ppm of lead - 100 ppm of heavy metals Eye preparations containing coal-tar color SJTPC 51
    52. 52. SALESJTPC 52
    53. 53. Sale of Drugs Classes of drugs prohibited to be sold Wholesale of biological (C/C1) Wholesale of other than those specified in C/C1 and X SJTPC 53
    54. 54. Class of drug prohibited to sale Misbranded, spurious, adulterated and drugs not of standard quality Patent/Proprietary drugs with undisclosed formula Sch-J drugs Expired drugs. Drugs used for consumption by government schemes such as, Armed force. Physician’s samples SJTPC 54
    55. 55. Wholesale of biological (C/C1) Adequate premises, with greater than 10 M2 area, with proper storage facility Drugs sold only to retailer having license Premises should be in charge of competent person who is Reg. Pharmacist. Records of purchase & sale Records preserved for 3 years from date of sale License should displayed on premises SJTPC 55
    56. 56. whole sale from other than specified in c/c1 and x All the conditions as discussed in for biological. Compounding is made by or under the direct and personal supervision of a qualified person. SJTPC 56
    57. 57. Labeling & PackagingAll the general and specific labeling and packaging specified to all classes of drugs and cosmetics should be as per the provisions made under the act. SJTPC 57
    58. 58. For allopathy Label SJTPC 58
    59. 59. For ayurvedic, siddha, unanihomoepathy and cosmeticsLABEL SJTPC 59
    60. 60. Schedules to the act First schedule – Names of books under Ayurvedic and Siddha systems Second schedule – Standard to be complied with by imported drugs and by drugs manufactured for sale, sold, stocked or exhibited for sale or distribution SJTPC 60
    61. 61. Schedules to the rulesTYPE CONTENT“A” Performa for forms( Application, issue, renewal, etc.)“B” Rates of fee for test or analysis by CDL or Govt. analysts“C” List of Biological and special products (Injectable) applicable to special provisions.“C1” List of Biological and special products (nonparenteral) applicable to special provisions.“D” List of drugs that are exempted from provisions of import“E1” List of poisonous substances under the Ayurvedic , Siddha and Unani systems“F” Provisions applicable to blood bank SJTPC 61
    62. 62. Schedules to the rulesTYPE CONTENT“F1” Special provision applicable to biological and special products, eg. Bacterial and viral vaccines, sera from living animals, bacterial origin diagnostic agents“F2” Standards for surgical dressings“F3” Standards for umbilical tapes“FF” Standards for ophthalmic preparations“G” List of substances required to be used under medical supervision and labelled accordingly“H” List of substances (prescription) that should be sold by retail only on prescriptions of R.M.P. SJTPC 62
    63. 63. Schedules to the rulesTYPE CONTENT “J” List of diseases and ailments that drug should not claim to cure“K” List of drugs that are exempted from certain provisions regarding manufacture“M” Requirements of manufacturing premises, GMP requirements of factory premises, plants and equipments“M1” Requirements of factory premises for manufacture of Homeopathic medicines“M2” Requirements of factory premises for manufacture of cosmetics“M3” Requirements of factory premises for manufacture of medical devices“N” List of equipment to run a Pharmacy“O” Standards for disinfectant fluids SJTPC 63
    64. 64. TYPE CONTENT“P” Life period(expiry) of drugs“Q” Coal tar colors permitted to be used in cosmetics“R” Standards for mechanical contraceptives“R1” Standards for medical devices“S” Standards for cosmetics“T” Requirements (GMP) of factory premises for Ayurvedic, Siddha, Unani drugs“U” Manufacturing and analytical records of drugs SJTPC 64
    65. 65. Schedules to the rulesTYPE CONTENT“U1” Manufacturing and analytical records of cosmetics“V” Standards for patent or proprietary medicines“W” List of drugs marketed under generic names- Omitted“X” List of narcotic drugs and psychotropic substances“Y” Requirement and guidelines on clinical trials for import and manufacture of new drugs SJTPC 65
    66. 66. Drugs and Cosmetics (Amendment)Act, 2008Salient features of the Act:- Substantial enhancement in punishment Life imprisonment for offenders involved in manufacture, sale and distribution of spurious and adulterated drug likely to cause grievous hurt Minimum punishment of seven years which may extend to life imprisonment Provision for compensation to affected person SJTPC 66
    67. 67. Different types of forms Forms. SJTPC 67
    68. 68. QUESTIONS Describe the functions of Central Drug Laboratory. Sale of drugs according to Drugs and Cosmetic Act. Describe the administration of Drug and cosmetics act Manufacture of drugs according to Drugs and Cosmetics Act. SJTPC 68
    69. 69. References www.cdsco.nic.in “Pharmaceutical Jurisprudence”, Jani GK, Atul prakashan; Fifth edition(2005-06); 28. “Forensic Pharmacy”, Kokate CK and Gokhle SB, Pharma Book Syndicate; 152 “Laboratories” http://www.gujhealth.gov.in/fdc- laboratory.htm SJTPC 69
    70. 70. SJTPC 70